As our core global equity solution, EquiSar invests in companies that are expected to be the main beneficiaries of key global trends no matter where these companies are headquartered.The fund seeks to achieve long term capital growth in sterling terms through an internationally diversified portfolio of equities.EquiSar's pioneering global thematic investment process has been in place for 15 years delivering strong long-term performance.
Name | % Net Assets |
---|---|
PNC Financial Services | 2.5% |
Fresenius Medical Care | 2.4% |
Occidental Petroleum | 2.4% |
Hartford Financial Services | 2.4% |
Wal-Mart Stores | 2.4% |
Unicharm | 2.3% |
Home Depot | 2.3% |
BorgWarner | 2.2% |
Pfizer | 2.2% |
Swiss Re | 2.2% |
Key | % Net Assets |
---|---|
PNC Financial Services | 2.5% |
Fresenius Medical Care | 2.4% |
Occidental Petroleum | 2.4% |
Hartford Financial Services | 2.4% |
Other | 90.3% |
Date | 21-Nov-2024 |
---|---|
NAV | 1,847.00p |
Currency | GBP |
Change | 4.00p |
% | 0.22% |
YTD change | 204.00p |
YTD % | 12.42% |
Fund Inception | 01/07/1994 |
---|---|
Fund Manager | Harry Talbot-Rice / Guy Monson |
TER | 1.71 (31-Dec-2013) |
Minimum Investment | |
---|---|
Initial | £1000 |
Additional | £250 |
Savings | £100 |
Charges | |
---|---|
Initial | 5.00% |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.05 |
You are here: research